|Day Low/High||101.45 / 103.13|
|52 Wk Low/High||98.24 / 130.47|
What the charts are telling us about the chemical stock.
Plus, Russia could provide a real-time clinical trial of a coronavirus vaccine.
This will be the ninth consecutive year when the big game tops that 100 million-viewers mark.
What's troubling is the wild abandon with which investors have been piling into these names.
Here's a window into what institutional investors may be doing and how to profit from that.
I continue to believe downside risks far outweigh the risks of a near-term rally.
The stock is in breakout mode after earnings, the problems of July left behind.
Basic materials is one of the sectors with some promising prospects.
A 50% retracement and a bullish divergence might be just enough support for EMN to begin to build a base.